Elevated PD-L1 expression on AML NPM1mut cells (a ratio of v1/v2, as determined by qPCR) is associated with poorer survival [106], suggesting that anti-PD-1 treatment could block this signaling pathway, enhance T cells’ killing of leukemic cells and cause an associated improvement in patient survival. Here, PDCD1 is linked to acute myeloid leukemia.